Cardiovascular Safety of Hydroxychloroquine in US Veterans With Rheumatoid Arthritis-Reference-Cited by-同舟云学术

Cardiovascular Safety of Hydroxychloroquine in US Veterans With Rheumatoid Arthritis

Published:2021-08-06 Issue:9 Volume:73 Page:1589-1600
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis Rheumatol

Author:

Faselis Charles¹,Zeng‐Treitler Qing²,Cheng Yan²,Kerr Gail S.³,Nashel David J.⁴,Liappis Angelike P.¹,Weintrob Amy C.²,Karasik Pamela E.⁵,Arundel Cherinne¹,Boehm Denise⁶,Heimall Michael S.⁶,Connell Lawrence B.⁷,Taub Daniel D.²,Shao Yijun²,Redd Douglas F.,Sheriff Helen M.²,Zhang Sijian⁶,Fletcher Ross D.⁶,Fonarow Gregg C.⁸,Moore Hans J.⁹,Ahmed Ali¹⁰^ORCID

Affiliation:

1. Washington DC VA Medical Center George Washington University, and Uniformed Services University Washington DC

2. Washington DC VA Medical Center and George Washington University Washington DC

3. Washington DC VA Medical Center Georgetown University, and Howard University Washington DC

4. Washington DC VA Medical Center and Georgetown University Washington DC

5. Washington DC VA Medical Center Georgetown University, George Washington University, and Uniformed Services University Washington DC

6. Washington DC VA Medical Center Washington DC

7. Providence VA Medical Center Providence Rhode Island

8. University of California Los Angeles

9. Washington DC VA Medical Center George Washington University Uniformed Services University Georgetown University, and US Department of Veterans Affairs Washington DC

10. Washington DC VA Medical Center George Washington University, and Georgetown University Washington DC

Funder

Health Services Research and Development

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.41803

Reference52 articles.

1. Considerations for Drug Interactions on QTc Interval in Exploratory COVID-19 Treatment

2. World Health Organization.The cardiotoxicity of antimalarials: WHO Evidence Review Group meeting 13–14 October 2016 Varembé Conference Centre Geneva Switzerland. March2021. URL:https://www.who.int/malaria/mpac/mpac‐mar2017‐erg‐cardiotoxicity‐report‐session2.pdf.

3. Hydroxychloroquine, Coronavirus Disease 2019, and QT Prolongation

4. Outcomes of hydroxychloroquine usage in United States veterans hospitalized with COVID‐19;Magagnoli J;Med (N Y),2020

5. Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Care Unit

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of antimalarials on the safety and persistence of treatment with biologic agents or Janus kinase inhibitors in rheumatoid arthritis;Rheumatology;2023-05-22

2. Association of Hydroxychloroquine Use with a Dose-Dependent Decrease in Mortality Risk in Patients with Elderly-Onset Rheumatoid Arthritis;Rheumatology and Therapy;2023-05-12

3. Hydroxychloroquine and Risk of Long QT Syndrome in Rheumatoid Arthritis: A Veterans Cohort Study With Nineteen‐Year Follow‐up;Arthritis Care & Research;2023-01-31

4. Risk of Arrhythmia Among New Users of Hydroxychloroquine in Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Population‐Based Study;Arthritis & Rheumatology;2023-01-11

5. Adverse events in rheumatoid arthritis patients under antimalarial treatment—Is there cardiovascular compromise?;Frontiers in Drug Safety and Regulation;2023-01-09